tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2616 Stock Latest News

CStone’s Sugemalimab Gains European Approval for Broader NSCLC Treatment
Company AnnouncementsCStone’s Sugemalimab Gains European Approval for Broader NSCLC Treatment
6d ago
2616
CStone Pharmaceuticals Unveils CS2015 at ACAAI 2025
PremiumCompany Announcements
CStone Pharmaceuticals Unveils CS2015 at ACAAI 2025
25d ago
2616
CStone Pharmaceuticals Advances CS2009 Clinical Trials with NMPA Approval
PremiumCompany Announcements
CStone Pharmaceuticals Advances CS2009 Clinical Trials with NMPA Approval
28d ago
2616
CStone Pharmaceuticals Announces Board Composition and Roles
PremiumCompany Announcements
CStone Pharmaceuticals Announces Board Composition and Roles
29d ago
2616
CStone Pharmaceuticals Announces Board Changes with New Appointment
PremiumCompany Announcements
CStone Pharmaceuticals Announces Board Changes with New Appointment
29d ago
2616
CStone Pharmaceuticals CEO Increases Shareholding, Signaling Confidence in Future Growth
PremiumCompany AnnouncementsCStone Pharmaceuticals CEO Increases Shareholding, Signaling Confidence in Future Growth
1M ago
2616
CStone Pharmaceuticals Unveils Promising Phase I Data for Innovative Cancer Therapy
Premium
Company Announcements
CStone Pharmaceuticals Unveils Promising Phase I Data for Innovative Cancer Therapy
1M ago
2616
CStone Pharmaceuticals Gains CHMP Positive Opinion for Sugemalimab in Stage III NSCLC
Premium
Company Announcements
CStone Pharmaceuticals Gains CHMP Positive Opinion for Sugemalimab in Stage III NSCLC
2M ago
2616
CStone Pharmaceuticals to Present Groundbreaking Clinical Data at ESMO 2025
PremiumCompany Announcements
CStone Pharmaceuticals to Present Groundbreaking Clinical Data at ESMO 2025
2M ago
2616
CStone Pharmaceuticals Initiates Global Phase II Trial for Innovative Cancer Therapy
PremiumCompany Announcements
CStone Pharmaceuticals Initiates Global Phase II Trial for Innovative Cancer Therapy
2M ago
2616
CStone Pharmaceuticals Appoints Kenneth Jarrett as Independent Director
PremiumCompany Announcements
CStone Pharmaceuticals Appoints Kenneth Jarrett as Independent Director
2M ago
2616
CStone Pharmaceuticals Announces Board Composition and Roles
PremiumCompany Announcements
CStone Pharmaceuticals Announces Board Composition and Roles
2M ago
2616
CStone Pharmaceuticals to Present Novel Antibody at ACAAI 2025
PremiumCompany AnnouncementsCStone Pharmaceuticals to Present Novel Antibody at ACAAI 2025
3M ago
2616
CStone Pharmaceuticals Grants Share Options and RSUs to Key Personnel
Premium
Company Announcements
CStone Pharmaceuticals Grants Share Options and RSUs to Key Personnel
3M ago
2616
CStone Pharmaceuticals Reports Significant Revenue Decline in H1 2025
Premium
Company Announcements
CStone Pharmaceuticals Reports Significant Revenue Decline in H1 2025
4M ago
2616
CStone Pharmaceuticals Schedules Board Meeting for Interim Results Review
PremiumCompany Announcements
CStone Pharmaceuticals Schedules Board Meeting for Interim Results Review
4M ago
2616
CStone Pharmaceuticals Advances Phase III Study for Liver Cancer Treatment
PremiumCompany Announcements
CStone Pharmaceuticals Advances Phase III Study for Liver Cancer Treatment
4M ago
2616
CStone Pharmaceuticals to Present Key Oncology Advances at ESMO 2025
PremiumCompany Announcements
CStone Pharmaceuticals to Present Key Oncology Advances at ESMO 2025
4M ago
2616
CStone Pharmaceuticals’ Phase III Study on CS1001 for NSCLC: A Market Game-Changer?
PremiumCompany Announcements
CStone Pharmaceuticals’ Phase III Study on CS1001 for NSCLC: A Market Game-Changer?
4M ago
2616
CStone Pharmaceuticals Completes HK$467.28 Million Share Placing to Boost R&D
PremiumCompany AnnouncementsCStone Pharmaceuticals Completes HK$467.28 Million Share Placing to Boost R&D
5M ago
2616
CStone Pharmaceuticals Secures NMPA Approval for Local Manufacturing of GAVRETO® in China
Premium
Company Announcements
CStone Pharmaceuticals Secures NMPA Approval for Local Manufacturing of GAVRETO® in China
5M ago
2616
CStone Pharmaceuticals Announces Share Placement to Raise HK$467 Million
Premium
Company Announcements
CStone Pharmaceuticals Announces Share Placement to Raise HK$467 Million
5M ago
2616

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >